Active substance
Results for the substance ganirelix
2 results
About this active substance
Ganirelix is a gonadotropin-releasing hormone (GnRH) antagonist used in in vitro fertilization (IVF) treatments to prevent premature ovulation. It works by blocking GnRH receptors, reducing luteinizing hormone (LH) secretion.
The medication is administered via subcutaneous injection, usually during the follicular phase of the menstrual cycle, as directed by a specialist. Ganirelix is effective in optimizing the timing of oocyte retrieval.
Common side effects include headaches, nausea, injection site reactions, and abdominal discomfort. It is important for the treatment to be monitored to ensure its efficacy and safety.
Ganirelix is an important component of IVF protocols, helping to increase the chances of procedural success.
The medication is administered via subcutaneous injection, usually during the follicular phase of the menstrual cycle, as directed by a specialist. Ganirelix is effective in optimizing the timing of oocyte retrieval.
Common side effects include headaches, nausea, injection site reactions, and abdominal discomfort. It is important for the treatment to be monitored to ensure its efficacy and safety.
Ganirelix is an important component of IVF protocols, helping to increase the chances of procedural success.